{
 "PrintNo":"A6629","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-03-23T11:26:12.312978Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-03-23","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":516,"Name":"Michael Cusick","Short":"CUSICK"}],
 "Title":"Provides that a fentanyl analogue shall be deemed to be a schedule I opiate",
 "Summary":"Provides that a fentanyl analogue shall be deemed to be a schedule I opiate.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3302 & 3306, Pub Health L; amd §220.00, Pen L",
 "ActClause":"AN ACT to amend the public health law and the penal law, in relation to fentanyl analogues",
 "SameAsPrintNo":"S1824-2021","PreviousVersions":["A2970-2017","A6757-2019"]
}